XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 30 filers reported holding XENON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $495,000 | -20.2% | 101,103 | -53.9% | 0.03% | -37.8% |
| Q4 2017 | $620,000 | +27.8% | 219,543 | +33.5% | 0.04% | +40.6% |
| Q3 2017 | $485,000 | -6.4% | 164,510 | 0.0% | 0.03% | -5.9% |
| Q2 2017 | $518,000 | +10.7% | 164,510 | +40.6% | 0.03% | -12.8% |
| Q1 2017 | $468,000 | +6.1% | 116,975 | +104.4% | 0.04% | -7.1% |
| Q4 2016 | $441,000 | -97.1% | 57,228 | +278.4% | 0.04% | 0.0% |
| Q3 2016 | $15,122,000 | – | 15,122 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |